Inside Health Folgen

Dr Mark Porter puts the Pharmaceutical Industry in the spotlight as some clinical trials are criticised for testing new drugs against a weaker rival so that the results appear much better than they really are. Kamran Abbasi takes on Dr Bina Rawal from the Association of British Pharmaceutical Industry to discuss if the hurdles are being set too low, so that a new therapy comes out on top.And what if sustained periods of adversity in childhood are associated with permanent structural changes in brain development? So suggests new research into adolescents with Conduct Disorder - a controversial diagnosis given to 1 in 20 teenagers in the UK with aggressive or anti-social behaviour. Many of these children will have been exposed to severe abuse, but do these findings have implications for common family discord that lasts months or years? Mark Porter investigates.

Is it safe to drink urine, or even sea water in a survival situation? Mark Porter examines calls to withdraw one of the most widely used anti inflammatory drugs, diclofenac, because it increases the risk of heart attacks. And what kinds of health problems can result from living with a parrot, cockatiel or a loft full of pigeons? As guidelines to improve hospital meals are introduced, how will the idea of food as medicine improve patients' experience?

Dr Mark Porter investigates a new shingles vaccine for the over 70s. Is a chicken pox vaccine for children an alternative? And contraception for the over 35s: can you take the pill until the menopause? Mark Porter finds out why we're so poor at First Aid. And if you're switching to cheaper drugs, does the size and colour influence how you take your medicine. Could changing to a cheaper brand have a hidden cost? And early clues to Parkinson's disease.